# 2025-21033: Center for Scientific Review; Notice of Closed Meetings

2025-21033, Center for Scientific Review; Notice of Closed Meetings, is a Federal Register notice from Health and Human Services Department, National Institutes of Health published 2025-11-25, effective 2026-01-14 (as of 2026-06-08).

- Canonical: https://policyrisk.com/federal-register/2025-21033
- As of: 2026-06-08
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2025-21033
- Title: Center for Scientific Review; Notice of Closed Meetings
- Type: Notice
- Agencies: Health and Human Services Department; National Institutes of Health
- Citation: 90 FR 53333
- Published: 2025-11-25
- Effective: 2026-01-14
- Comments close: not stated
- Significant: no
- Touches household money: no
- Regulation identifier numbers: none
- Last updated: 2026-06-08

## Summary

The Center for Scientific Review is holding a closed virtual meeting on January 14, 2026, to review special grant applications about fighting botulinum neurotoxins. These meetings are private to protect secret research info and personal details. Scientists applying for these grants should note the date and prepare for the review process, which helps decide who gets funding.

## Effects PRIA read

- NIH Grant Review Meeting Scheduled: benefit, low. Scientists and other applicants for RFA-AI-24-080 should note a virtual grant review meeting is scheduled for January 14, 2026 from 12:00 p.m. to 5:00 p.m. The panel will review and evaluate grant applications for “Broad Spectrum Products Against Multiple Neurotoxin Botulinum Serotypes (R61/R33 Cli…
- Review Closed to Protect Proprietary Data: benefit, low. The meeting will be closed to the public under 5 U.S.C. 552b(c)(4) and (c)(6) to protect confidential trade secrets, patentable material, and personal information in grant applications. This protects proprietary and personal details submitted with grant proposals.
- Clinical Trials Not Allowed for This RFA: cost, low. For RFA-AI-24-080 (Broad Spectrum Products Against Multiple Neurotoxin Botulinum Serotypes), the notice states “R61/R33 Clinical Trial Not Allowed,” so applicants must not propose R61/R33 clinical trials for this funding opportunity. Prospective applicants should ensure proposals do not include tho…

## Related documents

- [2026-20771](https://policyrisk.com/federal-register/2026-20771): Center for Scientific Review; Notice of Closed Meetings, 2026-10-09
- [2026-20705](https://policyrisk.com/federal-register/2026-20705): Prospective Grant of Exclusive License, Inter-Institutional Agreement-Institution Lead: Antibody Specifically Binding to Severe Fever With…, 2026-10-09
- [2026-20424](https://policyrisk.com/federal-register/2026-20424): National Cancer Institute; Notice of Meeting, 2026-10-06
- [2026-20365](https://policyrisk.com/federal-register/2026-20365): Center For Scientific Review; Notice of Closed Meetings, 2026-10-05
- [2026-20151](https://policyrisk.com/federal-register/2026-20151): Notice of NIH Tribal Consultations and Listening Session, 2026-10-01
- [2026-19719](https://policyrisk.com/federal-register/2026-19719): Center for Scientific Review; Amended Notice of Meeting, 2026-09-28

## Sources
- [2025-21033 on federalregister.gov](https://www.federalregister.gov/documents/2025/11/25/2025-21033/center-for-scientific-review-notice-of-closed-meetings)
- [2025-21033 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2025-11-25/pdf/2025-21033.pdf)

## Related
- [Previous: 2025-21032, Center for Scientific Review; Notice of Closed Meetings](https://policyrisk.com/federal-register/2025-21032)
- [Next: 2025-21034, Center for Scientific Review; Notice of Closed Meetings](https://policyrisk.com/federal-register/2025-21034)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2025-21033 (as of 2026-06-08).